ApoB tracking on GLP-1 — need advice

BariatricNurseD said:

The distinction that resolves most of these threads is between what is true on average and what is true for one person.

Coming at BariatricNurseD’s question from a different direction. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

The figures, for anyone assembling their own picture. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

Following on from BariatricNurseD — and this may be the naive question:

What did you change at the same time, and can you separate the two now?

lisa_labSD said:

If you are going to change something, change one thing and give it long enough to express itself.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. Filing an objection on the n=1 problem. Personal experience is genuine evidence about one person and very weak evidence about anybody else, and this thread keeps promoting the first into the second.

I would rather be corrected than agreed with, if it comes to it.

Reporting back.

Closing this out. What actually changed my mind was the point about waiting for a trend instead of reading a single measurement, which is embarrassing in hindsight and worth saying anyway.